Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
One of the major goals in cell culture process development for therapeutic antibody production is to develop methods to reach high titer in classical fed‐batch processes. This goal is often achieved through the optimizations of expression vector, cell line, media and cell culture process controls to increase cell specific productivity, viable cell density, and culture longevity. During process optimization for a selected production cell line, cell specific productivity (qP) can vary significantly with culture conditions. Therefore, identifying strategies to maintain maximal specific productivity throughout the entire fed‐batch culture and to eliminate cellular/process bottlenecks that prevent high levels of antibody production would be crucial for further advancements in this area. In this work, specific productivity was increased and maintained at high level throughout the course of the culture by the optimization of feed media and feeding strategy. Through the enhancement of nutrient feeding, final titer was increased by 2.5‐fold from the platform fed‐batch process and reached 7.5 g/L. In addition, further insight upon possible cellular bottlenecks in high yield antibody production was obtained by comparing the levels of heavy chain (HC) and light chain (LC) mRNA and the levels of intracellular antibody between the non‐optimized and optimized feeding processes. The mRNA levels of the two processes were measured and exhibited no significant difference suggesting that transcription is not the bottleneck. When intracellular antibody level was studied, the relatively constant level of HC, LC, and intact antibody between days 9 and 14 suggested that translation could be the rate‐limiting step under the non‐optimized nutrient feeding condition due to the dramatic drop of qP to roughly zero which correlated with the depletion of tyrosine as one of the key amino acids for protein synthesis. Finally, accumulation of unassembled HC but not intact antibody was observed at days 14–18 under the enhanced feeding condition, implying that folding and assembly may be the bottleneck toward the end of the culture. Bioeng. 2011; 108:1078–1088. © 2010 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Zhu, M. M., Goyal, A., Rank, D. L., Gupta, S. K., Boom, T. V., & Lee, S. S. (2008) · Biotechnology Progress · doi:10.1021/bp049815s · Cited by 199 · cited 2×
“…cell culture process have also been reported to impact qP, including (1) shift to lower culture temperature (Fox et al., 2005; Moore et al., 1997); (2) addition of small molecule enhancers such as sodium butyrate (Allen et al., 2008; Sung and Lee, 2005); (3) high osmolality (Zhu et al., 2005), etc.”
BackgroundChong, W. P. K., Reddy, S. G., Yusufi, F. N. K., Lee, D.-Y., Wong, N. S. C., Heng, C. K., Yap, M. G. S., & Ho, Y. S. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.03.018 · Cited by 97
BECKER, E., FLORIN, L., PFIZENMAIER, K., & KAUFMANN, H. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.03.008 · Cited by 86 · cited 1×
“The data reported in this study are consistent with previous results that suggested the relationship between antibody mRNA level and qP was not constant during the entire culture (Becker et al., 2008; Stansfield et al., 2007).”
ResultIdentification of novel small molecule enhancers of protein production by cultured mammalian cells
Allen, M. J., Boyce, J. P., Trentalange, M. T., Treiber, D. L., Rasmussen, B., Tillotson, B., Davis, R., & Reddy, P. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21839 · Cited by 54
Detailed understanding of enhanced specific antibody productivity in NS0 myeloma cells
Khoo, S. H. G., & Al‐Rubeai, M. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22041 · Cited by 38 · cited 3×
“…transcription efficiency by different level and ratio of heavy chain (HC) and light chain (LC) mRNA levels, which can potentially lead to increased final titer (Dorai et al., 2006; Jiang et al., 2006; Khoo and Al-Rubeai, 2009a; Lee et al., 2008; O’Callaghan et al., 2010; Schlatter et al., 2005).”
Background
Cited by
Ritacco, F. V., Wu, Y., & Khetan, A. (2018) · Biotechnology Progress · doi:10.1002/btpr.2706 · Cited by 273
Selection of chemically defined media for CHO cell fed-batch culture processes
Pan, X., Streefland, M., Dalm, C., Wijffels, R. H., & Martens, D. E. (2017) · Cytotechnology · doi:10.1007/s10616-016-0036-5 · Cited by 70
Fan, L., Frye, C. C., & Racher, A. J. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.56 · Cited by 35
Dadehbeigi, N., & Dickson, A. J. (2015) · Biotechnology Journal · doi:10.1002/biot.201500075 · Cited by 16
Metadata
- Authors
- Yu, M., Hu, Z., Pacis, E., Vijayasankaran, N., Shen, A., & Li, F.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2011-02-19
- Volume
- 108
- Issue
- 5
- Pages
- 1078-1088
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2109666318
- Cited by
- 80
- References
- 6
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process. https://app.cochat.ai/papers/10.1002/bit.23031
- The paper
- Yu, M., Hu, Z., Pacis, E., Vijayasankaran, N., Shen, A., & Li, F. (2011). Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.23031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.